Nov 30, 2017
1:6
For every 6 shares held, investors received 1. The price per share adjusted from $0.20 to $1.20.
The split itself did not change the total investment value.
Nexien BioPharma, Inc. (OTC:NXEN) operates in the Pharmaceuticals: major industry.
Nexien BioPharma, Inc. company overviewNexien BioPharma, Inc.'s most recent stock split was on November 30, 2017. It was a 1-for-6 reverse split, so shareholders received 1 share for every 6 they held.
Nexien BioPharma, Inc. (OTC:NXEN) has split its stock 3 times: a 1-for-2 reverse split on April 3, 1995, a 1-for-3 reverse split on July 22, 1999, and a 1-for-6 reverse split on November 30, 2017.
Nexien BioPharma, Inc. has split its stock 3 times. This history records 3 reverse splits between April 3, 1995 and November 30, 2017.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Nexien BioPharma, Inc.'s 1-for-6 reverse split on November 30, 2017, every 6 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Nexien BioPharma, Inc. has not announced a new split in our records. Its most recent split was on November 30, 2017, 8 years ago. Companies announce splits in advance, and any new OTC:NXEN split will appear on this page.